Loraz and Erythrocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Erythrocin (erythromycin lactobionate). Common drug interactions include nephrolithiasis among females and knee arthroplasty among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Erythrocin. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Erythrocin?

Erythrocin has active ingredients of erythromycin lactobionate. It is often used in tooth abscess. eHealthMe is studying from 1,200 Erythrocin users. Check the latest studies of Erythrocin.



On Jul, 11, 2026

24 people who take Loraz and Erythrocin together, and have interactions are studied.

Loraz and Erythrocin drug interactions.

What are the common drug interactions of Loraz and Erythrocin, by gender? *:

female:

  1. Nephrolithiasis (calculi in the kidneys)
  2. Pain
  3. Back pain
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Chronic kidney disease
  6. Alanine aminotransferase increased
  7. Aspartate aminotransferase increased
  8. Blood alkaline phosphatase increased
  9. Blood lactate dehydrogenase increased
  10. Fatigue (feeling of tiredness)

male:

  1. Knee arthroplasty
  2. Chronic kidney disease
  3. Pulmonary embolism (blockage of the main artery of the lung)
  4. Pyrexia (fever)
  5. Ulcerative keratitis (ulcerative inflammation of the cornea)
  6. Visual impairment
  7. Chills (felling of cold)
  8. Interstitial lung disease
  9. Pain in extremity
  10. Pallor

What are the common drug interactions of Loraz and Erythrocin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Back pain
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Blood alkaline phosphatase increased
  6. Blood lactate dehydrogenase increased
  7. Gamma-glutamyltransferase increased
  8. Influenza like illness
  9. Pyrexia (fever)
  10. Blood bilirubin increased

30-39:

n/a

40-49:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Rash
  3. Ulcerative keratitis (ulcerative inflammation of the cornea)

50-59:

  1. Knee arthroplasty
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Anaemia (lack of blood)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Hypertension (high blood pressure)
  7. Impaired gastric emptying
  8. Mitral valve disease mixed (disease process involving one or more of the valves of the heart)
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Dyspnoea (difficult or laboured respiration)
  6. General physical health deterioration (weak health status)
  7. Injury
  8. Pain
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Visual impairment

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 29.17%
  2. Depression: 6 people, 25.00%
  3. Pain: 5 people, 20.83%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 20.83%
  5. Insomnia (sleeplessness): 5 people, 20.83%
  6. High Blood Pressure: 5 people, 20.83%
  7. Infection: 5 people, 20.83%
  8. Cough: 4 people, 16.67%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 16.67%
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Erythrocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Erythrocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Erythrocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythrocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and erythromycin lactobionate (the active ingredients of Loraz and Erythrocin, respectively), and Loraz and Erythrocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: